title: BK virus prophylaxis with levofloxacin--reply.
authors.affiliation: Division of Nephrology, University of British Columbia, Vancouver, Canada.
authors.forename: John S
authors.initials: JS
authors.lastname: Gill
authors.affiliation: Division of Nephrology, University of Ottawa, Ottawa, Ontario, Canada.
authors.forename: Greg A
authors.initials: GA
authors.lastname: Knoll
authors.affiliation: Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
authors.forename: Atul
authors.initials: A
authors.lastname: Humar
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis; D001739:BK Virus / Q000302:isolation & purification*; D005260:Female; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D016030:Kidney Transplantation; D064704:Levofloxacin / Q000627:therapeutic use*; D008297:Male; D027601:Polyomavirus Infections / Q000517:prevention & control*; D014412:Tumor Virus Infections / Q000517:prevention & control*
chemical_list: D000900:Anti-Bacterial Agents; D064704:Levofloxacin